Evotec and Almirall enter into research collaboration in the field of dermatological diseases

Hamburg, Germany, 17 Sep 2018

Evotec AG and  Almirall, S.A. today announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics through a novel approach to disrupt cell signalling, that is expected to deliver highly potent and durable treatments for debilitating dermatology diseases such as psoriasis and atopic dermatitis.